Trial Profile
Antibiotic Combination Therapy with Bramitob in Patients with Cystic Fibrosis with Chronic Pseudomonas Infection of the Lung
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 May 2019
Price :
$35
*
At a glance
- Drugs Tobramycin (Primary) ; Colistin
- Indications Cystic fibrosis; Pseudomonal infections
- Focus Adverse reactions
- Acronyms KOBRA
- 02 Apr 2013 Status changed from recruiting to completed as reported by German Clinical Trials Register record.
- 17 Mar 2012 New trial record